Literature DB >> 12362296

Retransplantation for recurrent hepatitis C.

Rafik M Ghobrial1.   

Abstract

1. Primary orthotopic liver transplantation (OLT) for hepatitis C is performed with good results. 2. Re-OLT in hepatitis C virus (HCV)-infected transplant recipients is performed mostly for indications other than recurrent disease in the short-term after primary OLT. 3. Progressive allograft injury and loss caused by recurrent disease predict an increased need for re-OLT for HCV recurrence in the long term. 4. Outcomes of re-OLT for recurrent hepatitis C are equivalent to results for other indications of re-OLT. 5. Good outcomes are obtained in selected patients when re-OLT is performed early in the course of recurrent disease before transplant recipients become critically ill.

Entities:  

Mesh:

Year:  2002        PMID: 12362296     DOI: 10.1053/jlts.2002.35861

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  8 in total

1.  Impact of MELD on waitlist outcome of retransplant candidates.

Authors:  H J Kim; J J Larson; Y S Lim; W R Kim; R A Pedersen; T M Therneau; C B Rosen
Journal:  Am J Transplant       Date:  2010-11-10       Impact factor: 8.086

Review 2.  De novo hepatocellular carcinoma occurring in a transplanted liver: case report and review of the literature.

Authors:  Anca Croitoru; Thomas D Schiano; Myron Schwartz; Sasan Roayaie; Ruliang Xu; Arief Suriawinata; M Isabel Fiel
Journal:  Dig Dis Sci       Date:  2006-10       Impact factor: 3.199

3.  Methods for Contrasting Gap Time Hazard Functions: Application to Repeat Liver Transplantation.

Authors:  Xu Shu; Douglas E Schaubel
Journal:  Stat Biosci       Date:  2016-09-26

4.  Analysis of long-term outcomes of 3200 liver transplantations over two decades: a single-center experience.

Authors:  Ronald W Busuttil; Douglas G Farmer; Hasan Yersiz; Jonathan R Hiatt; Sue V McDiarmid; Leonard I Goldstein; Sammy Saab; Steven Han; Francisco Durazo; Michael Weaver; Carlos Cao; Tony Chen; Gerald S Lipshutz; Curtis Holt; Sherilyn Gordon; Jeffery Gornbein; Farin Amersi; Rafik M Ghobrial
Journal:  Ann Surg       Date:  2005-06       Impact factor: 12.969

5.  Recurrent hepatitis C in liver allografts: prospective assessment of diagnostic accuracy, identification of pitfalls, and observations about pathogenesis.

Authors:  A J Demetris; B Eghtesad; A Marcos; K Ruppert; M A Nalesnik; P Randhawa; T Wu; A Krasinskas; P Fontes; T Cacciarelli; A O Shakil; N Murase; J J Fung; T E Starzl
Journal:  Am J Surg Pathol       Date:  2004-05       Impact factor: 6.394

Review 6.  Management of recurrent viral hepatitis B and C after liver transplantation.

Authors:  Marzia Montalbano; Guy W Neff
Journal:  Curr Gastroenterol Rep       Date:  2006-02

Review 7.  Management of hepatitis C infection after liver transplantation.

Authors:  Mazen Alsatie; Naga Chalasani; Paul Y Kwo
Journal:  Drugs       Date:  2007       Impact factor: 9.546

8.  Impact of comorbidity on waiting list and post-transplant outcomes in patients undergoing liver retransplantation.

Authors:  Mohammad A B Al-Freah; Carl Moran; Matthew R Foxton; Kosh Agarwal; Julia A Wendon; Nigel D Heaton; Michael A Heneghan
Journal:  World J Hepatol       Date:  2017-07-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.